Preferred Label : naratriptan hydrochloride;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 121679-19-4; 10X8X4P12Z;

Is substance : O;

UNII : 10X8X4P12Z;

InChIKey : AWEZYKMQFAUBTD-UHFFFAOYSA-N;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/portail/jcms/c_2771884/fr/naramig
https://www.has-sante.fr/portail/jcms/c_399009/fr/naramig-2-5-mg-comprime-pellicule-boite-de-2-naramig-2-5-mg-comprime-pellicule-boite-de-6
2017
false
France
French
antimigraine preparations
treatment outcome
tryptamines
piperidines
vasoconstrictor agents
administration, oral
migraine disorders
insurance, health, reimbursement
adult
naratriptan
naratriptan
serotonin 5-HT1 receptor agonists
naratriptan hydrochloride
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68686698
2012
France
summary of product characteristics
package leaflet
tablets
naratriptan
naratriptan hydrochloride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66793438
2012
France
summary of product characteristics
package leaflet
tablets
naratriptan hydrochloride
naratriptan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69871575
2012
France
summary of product characteristics
package leaflet
tablets
naratriptan hydrochloride
naratriptan

---
http://www.has-sante.fr/portail/display.jsp?id=c_461107
http://www.has-sante.fr/portail/jcms/c_1234489/naramig
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/naramig_14032012_avis_ct11023_2012-04-16_15-27-14_882.pdf
2012
France
French
antimigraine preparations
tablets
tryptamines
piperidines
vasoconstrictor agents
administration, oral
insurance, health, reimbursement
migraine disorders
naratriptan
naratriptan
serotonin 5-HT1 receptor agonists
naratriptan hydrochloride
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67586588
2008
France
French
antimigraine preparations
tablets
tryptamines
piperidines
vasoconstrictor agents
administration, oral
piperidines
tryptamines
vasoconstrictor agents
drug approval
drug labeling
migraine disorders
adult
drug interactions
pregnancy
breast feeding
receptors, serotonin, 5-ht1
naratriptan
naratriptan
naratriptan
serotonin 5-HT1 receptor agonists
serotonin 5-HT1 receptor agonists
naratriptan hydrochloride
naratriptan hydrochloride
summary of product characteristics
package leaflet

---
Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.